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INTRODUCTION 
Acute pancreatitis is an inflammatory disease of the pancreas that 
is associated with little or no fibrosis of the gland. The causes are many. 
Presentation of the disease varies from mild abdominal pain to shock, 
sepsis, multi organ failure or even death. The exact pathogenesis is not 
yet clearly understood. This may be due to relative inaccessibility to 
clinical experimental studies. The usual clinical scenario is a chronic 
alcoholic presenting with severe epigastric pain radiating to back with 
vomiting. Most of the patients have hyperamylesia. role of imaging with 
respect to ultrasound is limited. However, computerized tomography is 
very useful in diagnosing, assessing the severity and predicting the 
prognosis of acute pancreatitis. There are many prognostic indicators for 
acute pancreatitis namely Ranson’s criteria, Modified Glasgow’s criteria, 
APACHE score and Bedside Index of Severity in Acute Pancreatitis 
(BISAP). Many studies have been conducted using the above mentioned 
criterias . Our objective in this study is to combine both clinical 
(APACHE II) and imaging methods (Computerized tomography of 
abdomen) to assess the severity and predict the prognosis for acute 
pancreatitis. Though the APACHE II score is cumbersome to do, it can be 
done from the first day on a daily basis unlike Ranson’s criteria where 
there is a delay of 48 hours assessing the patient severity. 
 
 
ELIGIBILITY CRITERIA 
 
All patients admitted and diagnosed as having acute pancreatitis 
were analysed and considered for study. This was a prospective study 
undertaken in K.A.P.V. Government Medical College Hospital, Trichy 
from September 2011 to November 2013. 
 
EXCLUSION CRITERIA 
 Chronic pancreatitis patients 
 Acute exacerbation of chronic pancreatitis. 
 
 
AIM OF THE STUDY 
 
1. To assess the severity of acute pancreatits in K.A.P.V. Government 
Medical College, Trichy. 
2. To analyse management and outcome of patients with acute 
pancreatitis in our hospital. 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
Anatomy, Physiology, and Embryology of the Pancreas
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The healthy, mature pancreas functions silently to produce 
digestive enzymes and hormones. It usually comes to notice only when a 
pathologic alteration produces symptoms, frequently involving pain.  
 
The pancreas originates during early development of the 
gastrointestinal system, then differentiates and grows to produce a large 
gland stretching approximately 15 cm from the duodenum toward the 
spleen along the posterior body wall. It weighs approximately 90 g 
normally.  The exocrine pancreas produces and releases digestive 
enzymes into the duodenum. Hormones, including insulin, are released 
from the endocrine portion into the blood vascular system. 
 
Tracking the development of the pancreas from its first appearance 
in the primitive gut to the acquisition of its mature form can provide some 
understanding of its relationship with adjacent structures. (1).  
EARLY ANATOMIC FORMATIONS  
 
 
 
 
 
 
 
 
The pancreas and liver begin as epithelial buds from the primitive 
gut. Early in embryonic development the endoderm folds into a tube, the 
anterior part of which is the foregut. At the same time the precursors of 
major blood vessels form in the surrounding mesenchyme, which is 
important in early pancreatic development. The primitive aorta, paired 
anteriorly and fused into a single vessel in the region of the foregut, lies 
immediately dorsal to the gut. Primitive vitelline veins lie ventral to the 
gut. The primitive gut and the primitive vessels are, at this stage, tubes 
consisting solely of a single layer of epithelium. Interaction of the 
epithelium of the aorta with that of the gut induces proliferation of 
endodermal epithelium and the beginning of differentiation to form the 
dorsal primordium of the pancreas . A similar inductive process occurs 
where vitelline vein endothelium touches gut endoderm to produce 
ventral buds. The proliferating pancreatic buds express the Pdx1 gene, 
providing an early marker of pancreatic differentiation. (1). 
 
Dorsal and ventral pancreatic primordial are formed by the 
epithelium of dorsal and ventral buds.. The liver, gallbladder  also 
develop from the right ventral primordium. The epithelium expands as 
primordial tubules that branch as they grow into the surrounding 
mesenchyme. Mesenchyme is cellular at first. Adult connective tissue is 
derived from mesenchyme. Cells become more dispersed as 
differentiation toward adult extracellular matrix proceeds. 
 
 
 
Although some differentiation in genetic expression begins, the 
epithelial cells remain morphologically similar for some time. The 
branched primordial tubules, which appear as primitive ducts, may 
reunite within the primordium to form circular continuities. (1) 
 
The pancreas initially grows within a free mesentery, but 
subsequent changes convert it into a retroperitoneal organ. Rotation of the 
gut moves the duodenum from the midline to the right side, its middle 
segment pressed against the dorsal abdominal wall. The pancreas, carried 
along in the duodenal mesentery, similarly acquires a retroperitoneal 
position as the mesenteric layers fuse. 
 
Its location at the dorsal abdominal wall just posterior to the 
diaphragm places the pancreas into close association with a myriad of 
major vessels and nerves. The aorta gives off the celiac trunk on leaving 
the thoracic cavity and before passing along the dorsal surface of the 
pancreas. The superior mesenteric artery runs posterior to the pancreas to 
pass ventrally over the duodenum. The superior mesenteric vein, 
paralleling the artery, passes to the dorsal surface of the pancreas where it 
is joined by the splenic vein to form the hepatic portal vein. The thinner 
part of the pancreas over the superior mesenteric– hepatic portal vein is 
its neck, separating the head from the body. (1) 
 
 
The endocrine and exocrine components of the pancreas derive 
from the same population of cells. Differentiation of the cells comprising 
the primitive ducts leads along three main pathways. At intervals cells 
bud off the primitive ducts, proliferate into spheroidal groups, lose their 
contact with the lumens, and become the islets of Langerhans. At the ends 
and along the sides of the primitive ducts, differentiating cells produce 
the spheroidal and elongate collections that constitute the acini. The 
remaining cells stay approximately in their original relationship to 
become the mature ducts. 
 
EARLY CELLULAR CHANGES  
Early in embryonic development proliferation and differentiation 
of primitive duct cells produce the precursors of islets of Langerhans. The 
islet cells produced include those capable of expressing insulin, glucagon, 
somatostatin, or pancreatic polypeptide. Cells expressing each of these 
products are present by 14 weeks' gestational age. During the early stages 
of islet formation, some of the cells express markers for duct cells at the 
same time they express insulin; that is, they represent an intermediate 
stage between duct cells and mature islet cells. The duct markers 
disappear with increased age. 
 
 
 
 
ANATOMIC AND PHYSIOLOGIC CONSIDERATIONS  
Ductal Epithelial Cells  
 
Mature ducts form a barrier between the secretion products they 
carry in their lumens and the surrounding extracellular matrix. The 
epithelium constitutes a continuous layer lining the ducts. Ductal 
epithelial cells lie side-by-side with the apposing membranes at the 
luminal surface joined by tight junctions. Therefore interchange of fluid 
and ions between duct lumen and extracellular space must be a 
transcellular event regulated by the cells traversed. Larger ducts present a 
smooth, undulating surface toward the lumen. Tightly joined ductal cells 
display microvilli projecting into the lumen between tight junctions. In 
the absence of pancreatic disease, the ducts are surrounded by a 
connective tissue matrix with a small number of cells. With disease, 
however, such as chronic pancreatitis, the epithelial barrier may be 
missing in places, with accumulation of inflammatory cells and 
 
 
proliferation of blood vessels exposed directly to the lumen. In this 
condition interchange of substances and cells between lumen and the 
extracellular space of the pancreas can occur without the regulation 
normally provided by the ductal epithelium. (1) 
Acinar Cells  
 
Acinar tissue constitutes the greatest proportion of the mature 
normal pancreas. Like islet cells, early acinar cells are derived from 
primitive ducts. Acinar cells are present by the 4th month of gestation. 
Enzymes are synthesized in an abundant rough endoplasmic reticulum 
prominent in the base of acinar cells and packaged in the Golgi apparatus 
for storage. Many of the enzymes are stored in granules as precursor 
products (zymogens) mainly in the apex of acinar cells. Stimulation of the 
acinar cell releases zymogen granules at the cell membrane bordering on 
the acinar lumen. Activation of the enzymes occurs on entry into the 
duodenal lumen where enterokinase acts on the pancreatic juice 
 
 
conducted there through the pancreatic ductal system. Trypsin is 
activated, in turn activating other zymogens. 
Pancreatic ducts branch and rebranch, producing progressively 
more and smaller ducts. The smallest ducts are intimately associated with 
acini. Some duct cells form tight junctions with adjacent acinar cells. The 
result is a continuous lumen, surrounded by a continuous epithelium, 
from the ductal system through the acinar system. (1) 
Dysfunctional Cellular Changes  
Imposition of abnormal conditions on the pancreas leads to 
transdifferentiation, in which fully differentiated cells revert to another 
cell type. Relative proportions of components change when abnormal 
situations alter factors modulating cellular behavior. Some of the change 
can occur by necrosis and apoptosis. If, for example, acinar cells die 
while other cell types survive, their proportion decreases. A more 
complex change that occurs is the transition of cells backward along the 
path differentiation has taken. Acinar and islet cells transdifferentiate to 
ductal cells. The result is clusters of small ducts, called tubular 
complexes. Tubular complexes may be produced by obstruction of the 
ductal system or by genetic abnormalities. They are common in chronic 
pancreatitis and pancreatic cancer. Cell markers and morphology change 
as acinar cells revert to a ductal phenotype, signaling the expres-sion of 
different sets of genes. Furthermore, the cells that have secondarily 
 
 
acquired the ductal phenotype exist in the population that is susceptible to 
malignant transformation. (1) 
Cellular Membrane Function  
Pancreatic cells react to many hormones and neurotransmitters. 
Among the variety of receptors contained in their membranes are 
receptors for cholecystokinin, secretin, and acetylcholine. 
Release of secretin from the duodenum results in the secretion of 
bicarbonate-rich fluid into the ductal system. Secretin interacts with its 
receptor on the surface of ductal cells. Bicarbonate, generated within the 
cell through the action of carbonic anhydrase, is expelled into the duct 
lumen through the apical membrane via an exchange with chloride. The 
channel that supplies the lumen with chloride ions is the cystic fibrosis 
transmembrane conductance regulator that is defective in cystic fibrosis. 
Release of cholecystokinin results in secretion of digestive 
enzymes from acinar cells. Stimulation of secretion is accompanied by 
increased concentrations of intracellular calcium ions within acinar 
cells.The contents of the granules are released by the fusion of membrane 
of the zymogen granules with the apical membrane. It is likely that the 
main interaction on the basolateral membrane of human acinar cells is not 
between cholecystokinin and its receptor but between acetylcholine and 
its receptor. Human acinar cells do not react to cholecystokinin the same 
as in some species. Rather, it is likely that receptors for cholecystokinin 
 
 
on afferent fibers of the vagus nerve are activated, initiating stimulation 
of pancreatic secretion by vagal cholinergic pathways. 
 
Ligands and receptors normally interact within certain limits of 
concentration. In unusual situations the limits are exceeded. 
Supramaximal stimulation of acinar cells with the cholecystokinin, a 
procedure that produces experimental acute pancreatitis, makes their cell 
membranes permeable to large molecules, suggesting a mechanism for 
the initiation of acute pancreatitis. Perhaps overstimulation via the vagus 
nerve damages acinar membranes, allowing early events characteristic of 
pancreatitis. (1) 
 
Blood Supply  
 
 
 
 
The abundant blood supply of the pancreas comes from branches 
of the aorta that also serve adjacent abdominal organs. Arteries 
originating in the aorta branch to serve liver, stomach, spleen, and 
intestine in common with the pancreas. The celiac and superior 
mesenteric arteries constitute the primary arteries from which others are 
derived. The splenic and common hepatic arteries branch from the celiac. 
Dorsal and greater pancreatic arteries, in addition to smaller ones, branch 
from the splenic artery. The gastroduodenal artery gives rise to 
pancreaticoduodenal artery which anastomoses with the 
pancreaticoduodenal branches from the superior mesenteric artery. 
Perfusion of the islets of Langerhans is much greater than that of 
acinar tissue. One or more arterioles enter the islet to branch into a 
 
 
prominent capillary plexus. The fenestrated capillaries of the islets empty 
directly into the acinar capillary plexus. 
Veins of the pancreas drain eventually into the hepatic portal 
system, so may become involved in the spread of pancreatic cancer to the 
liver. Cancer may invade the hepatic portal vein along its path dorsal to 
the pancreas. (1) 
Lymphatic System  
Lymphatic vessels lie mostly in the connective tissue septa of the 
pancreas. They are not particularly numerous, they have thin walls, and 
they tend to collapse when not in situ, so they are difficult to observe. A 
few intralobular lymphatic vessels drain into the interlobular plexus. 
These, in turn, coalesce into larger vessels which tend to parallel the 
blood vessels serving the pancreas. Lymphatic vessels emerge on the 
surface of the pancreas to enter lymph nodes. Efferent vessels from 
multiple nodes empty eventually into the thoracic duct. 
In the normal situation the lymphatics carry mostly excess 
interstitial fluid so could be considered to serve as an overflow. In 
pathologic situations, other things gain access and are conducted. Lymph-
borne metastases of pancreatic cancer are found in primary and secondary 
lymph nodes interposed between the pancreas and the thoracic duct. 
Lymph nodes surround the pancreas and lie before and along the sides of 
the aorta and its branches. Many of the nodes are associated with blood 
 
 
vessels and may be described according to the vessel. Celiac, splenic, 
hepatic, gastroduodenal, pancreaticoduodenal, and superior mesenteric 
groups of nodes are described. Suprapancreatic and infrapancreatic 
groups lie immediately outside the pancreas. (1) 
Nervous System  
 
Sympathetic fibers carried primarily in the splanchnic nerves 
originate in the intermediolateral cell column of the spinal cord. 
Accompanying sensory fibers have their cell bodies in the dorsal root 
ganglia. Parasympathetic fibers are carried with accompanying sensory 
fibers in the vagus nerve, which is attached to the brain. Sympathetic 
innervation affects pancreatic vasculature. Parasympathetic innervation 
modulates secretion. However, normal control of pancreatic function is 
complex and relies on simultaneous regulated activity of all mechanisms, 
so that a defect in one component can affect another. Physiologic control 
of and response by the pancreas is mediated in part by peptidergic 
 
 
innervation.Among these neurotransmitters are substance P, neuropeptide 
Y, calcitonin gene-related peptide, and vasoactive intestinal polypeptide. 
Splanchnic and vagus nerves pass through a plexus of nerve fibers 
and ganglia distributed around the base of the celiac artery. The 
sympathetic fibers synapse on secondary neurons in the celiac ganglia in 
addition to contributing to the celiac plexus. The parasympathetic fibers 
and sensory fibers pass through the celiac plexus without synapse. 
Parasympathetic fibers synapse on cell bodies of secondary neurons that 
form ganglia within the pancreas. (1) 
Nerve fibers combine in the celiac plexus and are distributed to the 
substance of the pancreas as networks surrounding the arteries of supply. 
The nerves that are distributed thus are mixed; that is, a nerve may 
contain sympathetic, parasympathetic, and sensory fibers. The nerves are 
mainly unmyelinated. 
On direct intense stimulation of nerves, or because of damage to 
the perineurium and nerve fibers by invasion of pancreatic cancer or 
chronic inflammation accompanying chronic pancreatitis, pain may be 
induced and sustained. A logical approach to the treatment of unremitting 
pain is to interrupt the pathway conducting it. Common approaches have 
been to block the celiac plexus or to interrupt the splanchnic nerves since 
they are the principal pathways for pain conduction from the pancreas. 
 
 
The severity and breadth of pain generation may lead to 
incorporation, at least potentially, of other nerves that are less central to 
pain conduction from the pancreas. It is possible that sensory nerves in 
the vagus may contribute to pain generation under appropriate 
circumstances. The pancreas lies on the posterior abdominal wall, and 
pancreatic cancer may extend from the pancreas proper to involve spinal 
nerves. Branches of the phrenic nerve could become involved in pain 
transmission. (1) 
ETIOLOGY
2
  
Nearly 90% of all episodes of acute pancreatitis are attributable to 
gallstone disease and alcohol abuse. Further etiologies of acute 
pancreatitis and clinical associations are listed in Box. The most common 
are briefly discussed, including biliary tract stones, alcohol, 
postprocedural, trauma, hyperlipidemia, hyperparathyroidism/ 
hypercalcemia, hereditary, pancreas divisum, infection, medications, 
pregnancy, and idiopathic. (2) 
 
 
 
Etiology of Acute Pancreatitis and Clinical Associations  
Biliary tract stone disease 
Ethanol/alcohol abuse 
Trauma  
 
 Postprocedural  
 
 Post-ERCP 
 
 Postoperative 
 
 
 Direct blunt trauma 
Hyperparathyroidism/hypercalcemia 
Hyperlipidemia 
Hereditary pancreatitis 
Infections  
 
 Viral 
 
 Parasitic 
 
 Fungal 
 
 Bacterial 
Mechanical obstruction  
 
 Tumors 
 
 Pancreatic divisum 
 
 Duodenal obstruction 
Medications  
 
 Antibiotics: sulfonamides, tetracyclines 
 
 Calcium 
 
 Cardiovascular: clonidine, quinidine, warfarin 
 
 Diuretics: furosemide, thiazides, ethacrynic acid, diazoxide 
 
 Steroids: estrogen, glucocorticoids 
 
 Other: azathioprine, cimetidine, methyldopa, phenformin 
Pregnancy 
Scorpion (Tityus trinitatis) venom 
Idiopathic 
 
 
Biliary Tract Disease 
Although acute pancreatitis is documented in association with 
acalculous biliary tract disease, bile duct stones (choledocholithiasis) 
represent the most common form of associated biliary abnormality. The 
mechanism by which a gallstone may cause pancreatitis is not entirely 
clear, although gallstones have been implicated ever since Opie made the 
seminal observation in 1901.This led him to propose the "common-
channel hypothesis," in which a blockage below the junction of the 
biliary and pancreatic ducts would cause bile to flow into the pancreas, 
which could then be damaged by the detergent action of bile salts. 
Important objections to this theory include the anatomic reality that 
the majority of individuals have such a short common channel that a 
stone located there would block both the pancreatic and biliary ducts, 
effectively isolating the two systems. Also, the pressure in the bile duct is 
lower than the pancreatic duct and hence flow from bile duct to 
pancreatic duct is less likely.  
Another proposed mechanism of causation postulates that passage 
of a gallstone through the sphincter of Oddi renders it momentarily 
incompetent, permitting the reflux of duodenal juice containing activated 
digestive enzymes into the pancreatic ductal system. However, it is 
questionable whether the transit time through the sphincter of Oddi is 
long enough to cause sufficient incompetence. Finally, the observation 
 
 
remains that procedures designed to render the sphincter incompetent, 
such as sphincterotomy, do not routinely cause pancreatitis. 
Therefore, although it is reasonable to dismiss an incompetent 
sphincter of Oddi as an etiologic factor in acute pancreatitis, it is not as 
simple to dismiss the role of gallstones. A clinical study showed that 88% 
of patients with acute pancreatitis passed gallstones in their feces within 
10 days of the attack. This is in contrast to only 11% of gallstone patients 
who did not have pancreatitis, suggesting that the process of passing a 
gallstone may cause pancreatitis. 
This information justifies searching for a more likely causative 
factor than abnormal bile or duodenal juice backflow into the pancreas. A 
common phenomenon by which common bile duct stone, tumor or 
helminthic infection cause pancreatitis is by duct obstruction. Obstruction 
of the duct causes duct hypertension which leads to leakage of pancreatic 
juice from the duct into the parenchyma.the low pH in the parenchyma 
activates the proteases and trypsin. also the colocolization of inactive 
zymogens and lysosomal hydrolases in ductal hypertension lead to 
activation of pancreatic enzymes. (2) 
Alcohol 
Ethanol can induce pancreatitis by several methods. Various 
proposed theories include spasm of spinchter of oddi, increased secretion 
of pancreatic juice followed by precipitation,  induction of transient 
 
 
hyperlipedemic state, increased ductal permeability, reduced blood flow 
to the pancreas and direct toxic effect on pancreas.  
Tumors 
A tumor can cause pancreatits by blocking ducts leading to ductal 
hypertension ans extravasation of pancreatic enzymes into the 
parenchyma.  
Iatrogenic Pancreatitis 
Acute pancreatitis can be associated with a number of surgical 
procedures, most commonly those performed on or close to the pancreas, 
such as pancreatic biopsy, biliary duct exploration, distal gastrectomy, 
and splenectomy. Acute pancreatitis is associated postoperatively with 
Billroth II gastrectomy and jejunostomy, in which increased 
intraduodenal pressure can cause backflow of activated enzymes into the 
pancreas. However, pancreatitis also can occur in association with 
surgery that uses low systemic perfusion, such as cardiopulmonary 
bypass and cardiac transplantation. Acute pancreatitis has been reported 
to be associated with severe hypothermia, and the hypothermia associated 
with cardiopulmonary bypass may be similarly causative. It also is 
possible that atheromatous emboli or ischemia may cause pancreatic 
injury. Most commonly, endoscopic retrograde 
cholangiopancreatography (ERCP) results in pancreatitis in 2 to 10% of 
patients, due to direct injury and/or intraductal hypertension. (2) 
 
 
Drugs 
For practical reasons, it often is difficult to implicate a drug as the 
cause of pancreatitis. Many drugs can produce hyperamylasemia and/or 
abdominal pain, and a drug is considered suspect if the pancreatitis-like 
illness resolves with its discontinuation. Certain drugs are known to be 
capable of causing acute pancreatitis. These include the thiazide diuretics, 
furosemide, estrogens, azathioprine, L-asparaginase, 6-mercaptopurine, 
methyldopa, the sulfonamides, tetracycline, pentamidine, procainamide, 
nitrofurantoin, dideoxyinosine, valproic acid, and acetylcholinesterase 
inhibitors. 
Infections 
Though mumps, coxsackievirus, and Mycoplasma pneumoniae are 
believed to be capable of inducing acute pancreatitis by infecting the 
acinar cells, none of these agents has been isolated from a diseased 
pancreas.  
Hyperlipidemia 
It has been suggested that lipase can liberate large amounts of toxic 
fatty acids into the pancreatic microcirculation. This could lead to 
endothelial injury, sludging of blood cells, and consequent ischemic 
states 
 
 
Miscellaneous Causes 
Hypercalcemic states arising from hyperparathyroidism can result 
in both acute and chronic pancreatitis; the mechanism most likely 
involves hypersecretion and the formation of calcified stones 
intraductally. Also implicated are infestations by Ascaris lumbricoides 
and the liver fluke Clonorchis sinensis, which is endemic to China, Japan, 
and Southeast Asia. These cause Oriental cholangitis, which is associated 
with cholangiocarcinoma obstructing the pancreatic duct. A dominant 
gene mutation following Mendelian inheritance is known to result in 
hereditary pancreatitis. Whitcomb and associates described several 
families from various parts of the world who have mutations in their 
cationic trypsinogen gene PRSS1, which results in pancreatitis.
32
 
Additionally, 20 to 45% of patients with pancreas divisum (unfused ducts 
of Wirsung and Santorini) develop pancreatitis, but the failure of 
procedures to improve drainage of the lesser papilla in reducing attacks of 
pancreatitis, as well as the observed lack of ductal dilatation in such 
patients, argues against pancreas divisum as an etiologic factor, rendering 
the role of this condition as yet unclear. Other implicated factors include 
azotemia, vasculitis, and the sting of the Trinidadian scorpion Tityus 
trinitatis. This scorpion's venom has been shown to cause 
neurotransmitter discharge from cholinergic nerve terminals, leading to 
massive production of pancreatic juice. Poisoning with 
 
 
antiacetylcholinesterase insecticides has a similar effect. Finally, no 
apparent cause can be ascribed to some episodes of acute pancreatitis, and 
these constitute the group referred to as idiopathic pancreatitis. Some of 
these patients are eventually found to have gallstone-related pancreatitis, 
which calls for caution in labeling any episode "idiopathic." (2) 
CLINICAL PRESENTATION  
The spectrum of clinical presentations of acute pancreatitis is 
broad. Fortunately, 90% to 95% of patients simply experience a mild, 
self-limiting bout of acute pancreatitis. Though much less common, 5% 
to 10% of patients develop a severe, life-threatening episode associated 
with a prolonged hospitalization, intensive care unit (ICU) stay, and 
increased morbidity. 
The cardinal symptom of acute pancreatitis is the insidious onset of 
constant epigastric pain, which often radiates to the back; however, other 
symptoms including anorexia, nausea, emesis, abdominal mass, or fever 
are often present. Patients with severe, necrotizing acute pancreatitis may 
develop jaundice, hypotension, shock, and signs of retroperitoneal 
hemorrhage, specifically an ecchymotic discoloration of the flank (Grey 
Turner's sign), the umbilicus (Cullen's sign), or the inguinal ligament 
(Fox's sign). (2) 
 
 
 
 
DIAGNOSIS 
Laboratory Tests  
Routine blood investigations namely complete blood count, renal 
function tests, liver function tests, blood sugar, serum amylase are usually 
done. Hemoconcentration greater than 44%, elevated renal parameters, 
CRP >150mg/ml often indicate poor prognosis. (8) 
Serum amylase and lipase remain the most widely used laboratory 
tests. The sensitivity of amylase is relatively low since there are multiple 
causes of hyperamylasemia unrelated to acute pancreatitis. However, 
concurrently increased lipase and amylase in the setting of abdominal 
pain increases the sensitivity and specificity of diagnosing acute 
pancreatitis to 90% and 95%, respectively. Although diagnostic, serum 
amylase and lipase levels have not been found to correlate with 
pancreatitis severity. Fractionation of plasma amylase isoenzymes and the 
calculation of fractional amylase excretion may be helpful in patients 
with nonpancreatic sources of hyperamylasemia or with renal failure. 
Nevertheless, the advent of computed tomographic (CT) scan has 
rendered these latter tests nearly obsolete. (2) 
 
 
 
 
 
 
Hyperamylasemia Unrelated to Acute Pancreatitis  
 
 Abdominal  
 
 Acute appendicitis 
 
 Biliary tract disease and gallstones 
 
 Intestinal obstruction and ischemia 
 
 Liver diseases 
 
 Pancreatic fistula 
 
 Peritonitis 
 
 Pregnancy 
 
 Perforated viscus 
 
 
 Impaired amylase secretion  
 
 Renal dysfunction 
 
 Nephrolithiasis 
 
 Macroamylasemia 
 
 Bisalbuminemia 
 
 
 Metabolic disorders  
 
 Diabetic ketoacidosis 
 
 
 Salivary gland disorders/injury  
 
 Calculi 
 
 Hypersecretion 
 
 Irradiation sialadenitis 
 
 Mumps 
 
 Parotitis 
 
 
 Trauma  
 
 Burns 
 
 Cerebral trauma 
 
 Multiple trauma 
 
 
 
 
 
Radiologic Studies  
Chest x ray and abdominal x ray erect view may show dilated ileal 
loops, abrupt cut off of transverse colon, pleural effusion, lung collapse or 
rarely calcification in the pancreas.  
Ultrasonographic Evaluation 
Ultrasound abdomen may show diffused enlarged gland with acute 
fluid collecton but role of ultrasound is limited because of the overlying 
gas shadow. Also the retroperitoneal fluid collection may not be properly 
visualised by ultrasound. 
CT Abdomen. 
 
Computerized tomography of abdomen is considered the GOLD 
STANDARD in diagnosis of acute pancreatitis. In patients with normal 
renal parameters, around 100 – 150 ml of intravenous contrast (8 – 10 
mm collimation) at a rate of 3ml/second is injected. The rationale behind 
this is in patients with normal pancreas and mild interstitial pancreatits, 
 
 
the capillary network is intact and the contrast uptake also is uniform 
resulting in uniformly enhanced gland. In patients with severe pancreatitis 
where there is destruction of the gland, the uptake is patchy. Diffuse or 
localized areas of non enhanced areas are considered as pancreatic 
necrosis. Based on gland necrosis a scoring system is made and the 
prognosis of the patient is known. The sensitivity of CT is 87% and 
specificity is 100%. (9). The correlation of CT grading and mortality is 
patients who have a severity index of 0 or 1 exhibited a 0% mortality rate 
and no morbidity, while patients with severity index of 2 have no 
mortality and a 4% morbidity rate. In contrast, a severity index of 7–10 
yielded a 17% mortality rate and a 92% complication rate. CT is taken 
usually on third day from clinical onset of pancreatitis attack because 
zones of tissue liquefaction become better defined and more easily 
recognized 2–3 days after the initial onset. Certain pitfalls of CT scan 
should also be borne in mind. CT taken within 24 -48 hours of onset of 
pancreatitis may not be useful. Interstitial fliud collection, interstitial 
edema, fatty infiltration into pancreas may sometimes be misinterpreted 
as pancreatic necrosis. Retro pancreatic fat necrosis cannot be diagnosed 
or quantified using CT scan. (3) 
 
 
 
 
 
 
 
 
CT Severity Index 
The CT severity index is an attempt to improve the early prognostic value 
of CT in cases of acute pancreatitis . Patients with grade A–E pancreatitis 
are assigned zero to four points plus two points for necrosis of up to 30%, 
four points for necrosis of 30%–50%, and six points for necrosis of more 
than 50%. (3) 
CT SEVERITY INDEX AND MODIFIED CT SEVERITY INDEX 
Characteristics CTSI (0–10) MCTSI (0–10) 
Pancreatic 
inflammation 
  
Normal pancreas 0 0 
Focal or diffuse 
enlargement of 
pancreas 
1 2 
Peripancreatic 
inflammation 
2 2 
Single acute fluid 
collection 
3 4 
Two or more acute 
fluid collections 
4 4 
Pancreatic 
parenchymal necrosis 
  
None 0 0 
Less than 30% 2 2 
Between 30% and 50% 4 4 
More than 50% 6 4 
 
 
  Modified CT severity index has Extrapancreatic complications 
which include One or more of pleural effusion, ascites, vascular 
complications, parenchymal complications, or gastrointestinal tract 
involvement. This is given 2 points. (8) 
 
Magnetic Resonance Imaging 
In patients with elevated renal parameters and allergic reactions to 
contrast, MR can be used. Gadolinium-enhanced T1-weighted gradient-
echo MR images can depict pancreatic necrosis as areas of nonenhanced 
parenchyma. T2- weighted images can accurately depict fluid collections, 
pseudocysts, and areas of haemorrhage. (8) 
 
PROGNOSTIC INDICATORS  
Ranson's criteria are the most commonly used scoring system. 
Patients with one or two criteria have a predicted mortality of less than 
1% compared to patients with three criteria (10%) or four criteria (15%); 
with more than seven criteria, the predicted mortality approaches 50%. 
Disadvantage of this criterion is that we have to wait for 48 hours to 
completely assess the patient. 
 
 
 
Ranson's Criteria Nonbiliary Acute 
Pancreatitis 
Biliary Acute 
Pancreatitis 
Admission 
Age (yr) >55 >70 
WBC count 
(×1000/mm
3
) >16 >18 
Glucose (mg/dl) >200 >220 
AST (IU/L) >250 >250 
LDH (IU/L) >350 >400 
Within 48 Hours of Admission 
Hematocrit decrease 
(points) 
>10 >10 
BUN increase (mg/dl) >5 >2 
Base deficit (mEq/L) >4 >5 
Fluid replacement (L) >6 >4 
PaO2 (mm Hg) <60 <60 
Calcium (mg/dl) <8 <8 
 
AST, aspartate aminotransaminase; BUN, blood urea nitrogen; LDH, 
lactate dehydrogenase; WBC, white blood cell.  
 
 
 
 
Modified Glasgow criteria are based on eight clinical and laboratory 
parameters measured within 48 hours of admission. Its limitations are 
similar to Ranson's criteria.  
Modified Glasgow Criteria: Within 48 Hours of Admission  
Criteria Value 
Age (yr) >55 
WBC count (×1000/mm
3
) >15 
Glucose (mg/dl) >180 
BUN (mg/dl) >45 
LDH (IU/l) >600 
Albumin (g/dl) <3.3 
PaO2 (mm Hg) <60 
Calcium (mg/dl) <8 
 
BUN, blood urea nitrogen; LDH, lactate dehydrogenase; WBC, white 
blood cell.  
Acute Physiology and Chronic Health Evaluation (APACHE)-II 
scoring system incorporates 12 physiologic and laboratory parameters as 
well as age and comorbid conditions to estimate severity of any disease 
process. Specifically, a score greater than 9 signifies severe, acute 
pancreatitis. The APACHE-II scoring system overcomes the 
shortcomings of Ranson's criteria such that it can be determined on a 
daily basis. (4) 
 
 
a: acute physiology score (12 
variables) 
high abnormal rage  low abnormal range 
Physiological Variables +4 +3 +2 +1 0 +1 +2 +
3 
+4 
Temperature – rectal (°C) >41 39-40.9  38.5–
38.9 
36–38.4 34–
35.9 
32–33.9 30–
31.9 
<29.0 
Mean arterial pressure (mm hg) >160 130–159 110–129  70–109  50–69  <49 
heart rate-ventricular response >180 140–179 110–139  70–109  55–69 40–
54 
<39 
Respiratory rate non ventilated 
or ventilated 
>50 35–49  25–34 12–24 10–11 6–9  <5 
Oxygen: A – a DO or PaO 
(mm hg) FiO2 > 0.5 
record A – aDO2 
FiO < 0.5 record only PaO 
2                                                              
2 
>500 350-499 200–349  <200 
PO >70 
2 
PO 61–
70 
 PO 
55–60 
PO <55 
Arterial ph >7.7 7.6–7.69  7.5-7.59 7.33–
7.49 
 7.25–
7.32 
7.15–
7.24 
<7.15 
Serum hCO  – only if no ABGs 
3 
>52 41.5–1.9  32–40.9 23–31.9  18–21.9 15–
17.9 
<15 
Serum sodium (mmol/I) 180 160–179 155–159 50–154 130–149  120–129 111–
119 
<110 
Serum potassium (mmol/I) >7 6–6.9  5.5–5.9 3.5–5.4 3–3.4 2.5–2.9  <2.5 
Serum creatinine (umol/l) >350 200–340 150–190  60–140  <60   
haematocrit (%) >60  50–50.9 46–49.9 30–45.9  20–29.9  <20 
White Blood cell court (x1000 
/mm3) 
>40  20–39.9 15–19.9 30–14.9  1–2.9  <1 
Glasgow Coma Score (GCS) Score = 15 minus actual GCS 
 
 
 
 
B. age points 
age years Points History Points for 
elective 
surgery 
Points for 
emergency 
surgery 
and non- 
operative 
patients 
 
 
apache ii score: 
sum of a + B + C 
> 44 0 Liver: Biopsy proven cirrhosis and 
documented portal hypertension or prior 
episodes of hepatic failure 
2 5 A: APS score 
45–54 2 Cardiovascular NYhA class IV 2 5 B: Age Points score 
55–64 3 Respiratory eg. Severe COPD, 
hypercapnia, home O2 pulmonary 
hypertension 
2 5 C: Chronic health 
points score 
65–74 5 Renal chronic dialysis 2 5  
> 75 6 Immunocompromised 2 5 Total apache II 
 
 
APACHE II score of more than 10 are high risk patients. These patients 
benefit from treatment in an ICU and it is worth while repeating the scores 
everyday to monitor the clinical state in these patients, in order to detect 
complications and to institute therapeutic modifications and also to monitor the 
efficacy of the treatment which is being instituted 
The APACHE II
4
 system is superior to other systems like Ranson’s, 
because it is the only system which takes into account all the major risk factors 
that influence the outcome from the disease including the acute physiological 
derangements, as well as the patient ability to recover which may be diminished 
by advancing age or chronic disease. Another advantage is that it can be 
calculated immediately after admission and can be repeated everyday, unlike 
other scoring systems for acute pancreatitis. The range of the APACHE II score 
is wide, providing a better spread between the mild and severe attacks because 
varying weights are assigned to increasingly abnormal values, rather than all or 
no judgements (4)  
Multiorgan Dysfunction Score (MODS)
8
 is similar to APACHE-II; this 
organ-injury based scoring system has been used to predict disease severity. 
When applied to acute pancreatitis, a score higher than 2 predicts early 
mortality. (8) 
 
 
 
 
 
Principles of Management 
 
 
 
 
 
 
Resuscitation and Monitoring
5
 
Patients with acute pancreatitis should be agressvely resuscitated with 
intravenous fluids at the rate of 150 -  200ml/hour. Inadequate resuscitation 
leads to renal insufficiency and increased pancreatic necrosis. However, care 
must be taken not to over load the patient for the fear of pulmonary edema. 
Strict input output chart has to be maintained on houly basis and urine output 
should be maintained more than 0.5ml/kg/hour.  
The old teaching was to keep the patient nil per mouth by inserting a ryles 
tube. In this way adequate rest is given to the pancreas and paralytic ileus is also 
dealt with. But new teaching is that all patients with pancreatitis need not be 
kept nil per oral. If there is severe vomiting and patient is in semi conscious 
state then ryles tube should be inserted to prevent aspiration pneumonia.  
Patients can be started with sips of water after 2 – 3 days if tolerated and 
gradually intake can be increased. In patients with severe pancreatitis and those 
who do not tolerate liquids, total parenteral nutrition may be an option. The 
disadvantages of TPN is high cost, catheter related complications and alteration 
in the intestinal mucosal barrier which may lead to further complications. (5) 
 ERCP 
ERCP definitely has a role in the presence of on-going biliary obstruction 
and cholangitis. There is no role in the absence of biliary obstruction. In fact, 
ERCP may be harmful in such cases. 
 
 
 
Prophylactic Antibiotics 
Authors, 
year 
No. of 
antibio
tics/ 
control 
No. of 
instituti
ons 
Antibiotics Outcomes Strengths/weaknesses 
Isenmann 
et al., 2004 
58/56 19 
Ciprofloxacin
, 
metronidazole 
No difference 
in pancreatic 
infections or 
mortality 
Prospective, 
randomized, adequately 
powered 
Luiten et 
al., 1995 
52/50 16 
Cefotaxime, 
colistin, 
amphoterecin 
B, 
norfloxacin 
Decreased 
local 
infections and 
mortality 
Utilized selective 
digestive 
decontamination 
Sainio et 
al., 
30/30 1 cefuroxime 
No difference 
in pancreatic 
infections, 
sepsis; 
decreased 
mortality 
Underpowered, single 
centre 
Pederzoli 
et al., 
33/41 6 imipenem 
Decreased 
local 
infections and 
sepsis; no 
difference in 
mortality. 
Unblended, 
underpowered, 
subgroup analysis. 
 
The role of antibiotics is much debated topic. The common organisms 
involved are E. coli, klebsiella, pseudomonas, staphylococcus and 
streptococcus. Rationale for using antibiotics is sepsis and MODS develop from 
local infection and hence by controlling the local infection, sepsis may be 
controlled. Antibiotics is of use only in early periods where the necrosis is less 
than 50%. The effectiveness of antibiotic also depends upon the ability of the 
 
 
drug to penetrate into the pancreas. Also there is a danger of development of 
antibiotic resistant organisms and fungal infections. The optimal duration of 
antimicrobial therapy has not been defined, although the incidence of pancreatic 
infection increases for approximately the first 3 weeks after diagnosis. A 
treatment course of 1–4 weeks therefore is recommended commonly. 
Prophylactic use of antifungals is still not yet clear. (5) 
Admission to an intensive care unit: 
  Mortality is generally a consequence of MODS. In the first two weeks, 
this risk is mainly related to a systemic inflammatory response. Then, mortality 
is usually associated with pancreatic necrosis and infection. Intensive care unit 
admission must be considered under the following circumstances: 
 (1) Persistent MODS for more than 48h and early onset (during the first week) 
because it is associated with 50% mortality;  
(2) Clinical manifestations predicting MODS development, according to clinical 
status, multiparametric systems (more than 3 Glasgow or Ranson analytical 
criteria at 48h or APACHE Ⅱ higher than 8), biochemical data (riboflavin 
carrier protein >150 mg/dLat 48h), radiological data (persistent pleural effusion 
for more than 48h after admission) or associated obesity;  
(3) Development of local complications. 
Surgical Management:  
Most of the cases are managed conservatively. The following are the indications 
for surgery. 
 
 
1. Infected pancreatic necrosis. 
2. Intra-abdominal catastrophe such as perforated viscus .severe sterile 
necrosis. 
3. Symptomatic organised pancreatic necrosis. 
4. Diagnostic uncertainity. 
 
 
 
 
 
 
 
Infected Pancreatic Necrosis 
The majority of deaths from acute pancreatitis occur in patients with 
infected pancreatic necrosis. The mortality rate is virtually 100% without 
intervention, although with appropriate surgical therapy it should approach the 
less than 15% mortality seen with sterile necrosis. A minority of patients with 
infected pancreatic necrosis may demonstrate radiographic evidence of such, 
emphysematous pancreatitis, or intraparenchymal gas. In most patients, CT-
guided percutaneous FNA is needed to diagnose infection. As noted previously, 
both severe sterile necrosis and infected pancreatic necrosis are associated with 
significant leukocytosis and fever, making clinical distinction impossible. 
Patients with severe pancreatitis or organ failure or those who fail to improve 
clinically in the first 2 weeks should be investigated for possible infected 
necrosis. (5) 
Severe Sterile Pancreatic Necrosis 
Necrosis of more than 50% may be considered as an indication for 
surgery but it is delayed till 3 weeks. There is no role of early surgery in acute 
pancreatitis. 
Organized Pancreatic Necrosis 
Some patients have persistent pain, malaise or inability to eat. Warshaw 
described this as persistent unwellness which in pathologic terms is organized 
pancreatic necrosis. There is clear demarcation from healthy pancreatic tissue 
and hence surgery in this condition should be delayed upto 3 – 4 weeks. 
 
 
Pancreatic Necrosis 
Pancreatic necrosis is defined as a diffuse or focal area of nonviable 
pancreatic parenchyma that typically is associated with peripancreatic fat 
necrosis. Necrosis can be sterile or infected. Infected pancreatic necrosis is the 
leading cause of death associated with severe acute pancreatitis. 
The risk of infected necrosis increases with the duration of illness and the 
extent of necrosis. The risk of infection increases from 24% by the end of the 
first week of illness, to 36% at the end of the second week, and to 71% by the 
end of the third week.
 
 
There are five routes by which bacteria can infect pancreatic necrosis: (1) 
hematogenous through mesenteric vessels to the portal circulation, (2) 
transpapillary reflux of enteric content into the pancreatic duct, (3) translocation 
of intestinal bacteria and toxins via the mesenteric lymphatics to the thoracic 
duct and the systemic circulation, (4) reflux of bacteriobilia via a disrupted 
pancreatic duct into the necrotic parenchyma, and (5) transperitoneal spread. (5) 
Timing of Surgery 
Surgery is usually done 3- 4 weeks after the onset because the 
demarcation of viable from nonviable tissue is better and chances of bleeding 
are less. 
Percutaneous Drainage
6
 
There are two settings in which percutaneous drainage is useful. The first 
is in an unstable septic patient with evidence of a tense rim-enhanced collection 
 
 
(pancreatic abscess) with a significant fluid component on CT scanning. The 
second setting in which percutaneous drainage is important is to establish the 
optimal route for dilatation and subsequent percutaneous necrosectomy, should 
this be appropriate. This will require careful discussion between the radiologist 
and surgeon. It usually involves a left-flank puncture and a route along the axis 
of the body/tail of the pancreas. (6) 
Surgery for Infected Necrosis 
 
 
 
 
 
 
 
 
 
 
 
 
Pancreatic resection is a historical approach that has been associated with 
unacceptable complication and mortality rates. Pancreatic necrosectomy 
involves removing the devitalized pancreatic and peripancreatic tissue and 
drainage of associated pus. The usual approach to the pancreas is through the 
gastrocolic omentum into the lesser sac. Sometimes it is easiest to enter the 
region through the transverse mesocolon, from the greater sac, and to the left of 
the DJ flexure. At the same time, it is useful to take down both colonic flexures, 
providing better exposure and reducing the risk of subsequent injury to the 
colon from tube drains. The head of the pancreas then can be approached 
anteriorly and posteriorly (after kocherization). If the abdomen is opened 
though a bilateral subcostal incision, in line with the opening to the lesser sac, 
subsequent laparotomies do not need to disturb the greater peritoneal sac or the 
 
 
upper abdomen. It is not necessarily a one-stage procedure, especially if an 
early necrosectomy is embarked on. Necrosectomy is a careful process, best 
accomplished by an educated finger. The extent of the cavity can be explored 
and the gentle separation of necrotic material accomplished. Necrotic extensions 
from the primary cavity need to be explored, often into the root of the small 
bowel mesentery and down the retrocolic gutters. Care must be taken to remove 
only what easily separates and to avoid injury to major vessels. The removal of 
necrotic material may be assisted by irrigation, pulsatile irrigation, gauze, and 
sponge forceps. When contained by a mature wall, it is advisable to avoid 
opening up the area too widely. The next step is placement of large-bore, soft, 
dependent drains to cover all the regions of what is often a complex area. 
Continuous lavage with peritoneal dialysis fluid, at flow rates of 300–1000 
mL/h, may reduce the need to reoperate and often is continued for 2–3 weeks. 
The most common postoperative complications are hemorrhage and fistulization 
(pancreas, small and large intestine). The use of packing is lifesaving for major 
hemorrhage that occurs at the time of necrosectomy, but when used routinely, it 
is associated with a higher incidence of enteric fistulas. (6) 
 
 
 
 
 
Prognosis 
              The prognosis of patients with necrotizing pancreatitis depends on the 
extent of necrosis and the onset of infection. The overall mortality associated 
with pancreatic necrosis is 30–40%. This is an average of two major 
components—the mortality associated with sterile necrosis, which is 0–11%, 
and that for infected necrosis, which is usually 20–40% but may reach as high 
as 70%. Most deaths are in the context of multiorgan failure. 
 
 
 
Pancreatic Abscess 
             The Atlanta definition
 
is a circumscribed intra-abdominal collection of 
purulent material containing little or no pancreatic necrosis. In contrast, infected 
necrosis is characterized by the extension of necrotic tissue in the pancreas and 
peripancreatic and/or retroperitoneal regions. The distinction between infected 
necrosis and pancreatic abscess is of importance because they are managed 
differently. The predominantly liquid contents of an abscess may be treated by 
percutaneous drainage, whereas the solid contents of infected necrosis will 
require debridement. (6) 
Diagnosis 
          The clinical hallmarks of abscess are well recognized, with the 
development of fever, tachycardia, abdominal pain, and leukocytosis. Although 
these features may be present already, abscess formation often is accompanied 
by a secondary deterioration in the patient's clinical course. A secondary 
elevation in serum CRP level also may occur. Confirmation of a pancreatic 
abscess is best obtained by a contrast-enhanced CT scan. A rim-enhancing fluid 
collection arising from a region of previous pancreatic necrosis or pseudocyst is 
highly suggestive. The presence of bacterial (and fungal) infection can be 
confirmed by CT-guided FNA. 
 
 
 
Treatment 
       If it is a pure pancreatic abscess with little or no necrosum, then 
percutaneous drainage may be done. However, the risk of developing pancreatic 
fistula is high. Hence percutaneous drainage through stomach with subsequent 
internelixation with a mushroom or J stent may be done. If it is bulging into the 
stomach or duodenum, endoscopy followed by drainage into stomach is done. 
(6) 
Hemorrhagic complications:  
Causes may include gastroduodenitis secondary toadjacent inflammation, 
rupture of pseudocyst, erosion of splenic artery or associated bleeding peptic 
ulcer. Diagnosis is by endoscopy and CT Angiography. Definitive therapy 
includes embolization or surgery. 
Pancreatic ascites and pancreatic effusion: 
Also termed pancreatic internal fistula, is usually due to chronic leakage 
from pseudo cyst secondary to alcoholic pancreatitis in adults or traumatic 
pancreatitis in children. Weight loss and abdominal distension are the features. 
May be diagnosed by ERCP. Prolonged nil per oral, nasojejunal feeding and 
stomatostation uaually works. Rarely stenting of the duct may be required. If the 
distal pancreas is involved, then distal pancreratectomy and  internal drainage 
like pancreatico jejunostomy is done. 
  
 
 
 
Abdominal and retroperitoneal collections: 
Collections in the retroperitoneum depends upon the nature of the 
collection, time since collection, communication with the main pancreatic duct. 
For collection less than 4 weeks, a pigtail catheter may be inserted(keeping in 
mind the risk of introcing an infection). Those communicating with main 
pancreatic duct may be stented. Those with semisolid debris may have to be 
evacuated surgically.  
Thrombosis of splenic vein and portal vein: 
Relatively rare. Subsides spontaneously after inflammation redeces. Main 
portal vein involement may warrant use of anti platelet drugs but the risk of 
intrapancreatic bleeding has to be kept in mind. 
 
PANCREATIC PSEUDO CYSTS: 
 
 
It is defined as peri pancreatic fluid collection contained by granulation 
tissue which does not have a epithelial lining (in contrast to pancreatic cystic 
neoplasm which has a epithelial lining).following an episode of acute 
 
 
pancreatitis, most of the pseudo cysts are located near the head region in the 
lesser sac but may also be formed in mediastinum, thorax, pelvis or scrotum. 
PATHOGENESIS OF PSEUDO CYSTS: 
 Pseudo cyst formation requires either pancreatic duct disruption or 
pancreatic duct obstruction. When there is disruption of the duct, the leakage of 
enzyme rich contents in the peritoneum incites marked inflammation. After a 
period of 4 – 6 weeks, the collection is contained by granulation tissue. The size 
of the cyst may remain static or enlarge if it communicates with the main 
pancreatic duct. Contents is usually sterile clear liquid. Haemorrhage causes 
xanthochromia. Necrotic material may be present after acute pancreatitis. 
Pseudo cysts may rupture causing ascites, or may compress onto the 
surrounding organs or may rupture causing pancreatico pleural/bronchial fistula. 
Pseudo cysts following trauma are usually located anterior to pancreas as the 
duct crosses the vertebra anteriorly. In chronic pancreatitis, pseudo cysts are 
formed due to duct blow outs. There is usually a stricture in the distal duct with 
the proximal duct communicating with the cyst. (6) 
 
 
 
 
The D'egidio Classification of Pancreatic Pseudocysts and the Primary 
Treatment Options (6) 
 Context Pancreatic 
duct 
Duct-
pseudocyst 
communication 
Primary 
treatment 
Type 1 Acute 
postnecrotic 
Pancreatitis 
Normal No Percutaneous 
drainage 
Type 2 Acute-on-
chronic 
Pancreatitis 
Abnormal (no 
Stricture) 
50:50 Internal 
drainage or 
Resection 
Type 3 Chronic 
pancreatitis 
Abnormal 
(stricture) 
Yes Internal 
drainage with 
duct 
Decompression 
 
 
 
Complications of psedocysts: 
1. Compression of stomach, duodenum, common bile duct. 
2. Rupture into peritoneum or pleural cavity. 
3. Infection. 
4. Thrombosis of splenic vein/ portal vein. 
5. Haemorrhage from splenic artery. 
Diagnosis and Management 
 
  In the absence of symptoms or evidence of enlargement, expectant 
management usually is reasonable. An enlarging asymptomatic pseudocyst that 
has been present for 6 weeks usually is treated. This relatively conservative 
approach is based on the low risk of complications. A natural-history study 
from India indicates that asymptomatic pseudocysts less than 7.5 cm in diameter 
 
 
and without internal debris will resolve spontaneously at an average of 5 
months.
 
 
There are two important rules in the treatment of pseudocysts. The first is 
that a cystic neoplasm must not be treated as a pseudocyst. The second is that 
elective external drainage of a pseudocyst must not be done if there is 
downstream and unrelieved pancreatic ductal obstruction because of the high 
risk of an external pancreatic fistula. 
The approach to treatment  depends on the nature of the pseudocyst, the 
pancreatic duct, and the fitness of the patient. 
The following features of a pseudocyst are important in considering the most 
appropriate treatment:  
 The thickness of the pseudocyst wall, which is usually a function of the 
duration of the pseudocyst. This is important because the operative 
drainage of a pseudocyst requires that it safely accept sutures or staples. 
After 4–6 weeks, this will not be an issue.  
 The location of the pseudocyst. If adherent to the stomach or duodenum, 
the options are different than if the pseudocyst is deep within the 
retroperitoneum and covered by bowel loops.  
 The contents of the pseudocyst. Blood may require prior embolization of 
a pseudoanuerysm. Pus will require drainage, percutaneous or open. 
Infected necrosum will require débridement.  
 
 
 The pancreas and the pancreatic duct need separate consideration in 
planning the treatment of a pseudocyst. The pancreas may warrant 
treatment in its own right, especially if there is a ductal stricture, a dilated 
duct, or regional disease warranting resection. (6) 
 
Open Surgical Treatment 
 
 
 
 
 
 
A D'Egidio type II pseudocyst is best treated by internal drainage or 
resection. When there is a mature wall, internal drainage is the best surgical 
option. Recurrence rates should be less than 5%, and mortality should be less 
than 2%. 
A pseudo cyst adherent to the posterior wall of stomach causing pressure 
symptoms is best treated by cysto gastrostomy. Those arising from body or tail 
of pancreas are treated by roux en Y cysto jejunostomy. In chronic pancreatitis a 
lateral pancreatico jejunostomy is done. Transduodenal drainage is done 
occasionally if the pseudo cyst impinges on the medial wall of duodenum. 
External drainage is done in critically ill patients, immature pseudo cysts with 
bleeding where under running has been done. External drainage with a trans 
 
 
papillary stent of the duct along with long acting stomatostatin analogue is a 
good option in such conditions. 
Radiologic Treatment 
Percutaneous drainage is best suited to D'Egidio type I pseudo cysts in 
which there is no significant underlying duct abnormality or communication 
between the duct and pseudo cyst. In the setting of acute pancreatitis, catheter 
drainage is severely hampered by the inability to allow the ready egress of 
necrotic and viscous material. In the setting of chronic pancreatitis, the 
downstream obstruction of the duct gives rise to a high recurrence rate and/or an 
external fistula along the catheter tract. In simple, uncomplicated pseudo cysts, 
percutaneous drainage usually is successful, although this is the group with the 
fewest symptoms, the lowest complication rate, and the best chance of 
spontaneous resolution. (6) 
The introduction of a transgastric approach to percutaneous drainage has 
almost abolished the problem of external pancreatic fistulas. This produces a 
percutaneous cystogastrostomy but requires an initial period of external 
transgastric drainage, clamping at 3 days, and then internalization at 2 weeks. 
Internalization can be helped with a concurrent endoscopic view, especially in 
the deployment of double pigtail catheters. The endoscopic approach is also 
used for the subsequent removal of the catheters. (6) 
 
 
 
 
MATERIALS AND METHODS 
 
 This is a prospective study of 50 patients admitted with features of Acute 
Pancreatitis in K.A.P.V. Govt. Medical college Hospital, Trichy from 
September 2011 to November 2013. This study includes the patients of Trichy 
district and adjacent districts of Karur, Dindigul and Namakkal who were 
admitted for acute pancreatitis. 
 
 A proforma is attached to all the case sheets who were diagnosed as 
having Acute Pancreatitis. Serum amylase is taken as a routine in all suspected 
cases. All the data were entered in the proforma and the patients were followed 
till discharge or  death. 
 The details of signs and symptoms, diagnosis, complications and outcome 
of the patient were entered in the proforma and they were tabulated and 
analysed. All the data obtained was entered in the master chart and tabulated for 
comparison and reference. 
 The observations were compared with the recent studies and literature 
available and conclusions were drawn.  
  
MEATHOD OF COLLECTION OF DATA 
Patients with acute onset of epigastric pain and vomiting who are 
suspected to have acute pancreatitis underwent serum amylase test. Those 
patients with elevated levels of serum amylase of more than 1000 IU underwent 
plain or contrast CT ABDOMEN on 3
rd
 day. Simultaneously blood 
 
 
investigations namely complete blood count, liver function test, renal function 
test, blood sugar, serum electrolytes and arterial blood gas analysis were done 
on the first day. The patients were graded according to Balthazar grading and 
modified CT severity index. The patients were given a score according 
APACHE II scoring system. Based on APACHE II scoring and CT grading, the 
severity, complications and prognosis of the patients was assessed. 
INVESTIGATIONS 
Hb% 
Total count 
Differential count 
ESR 
Blood urea 
Serum cretinine 
Sugar 
sr. Amylase 
sr. Electrolytes 
Total bilurubin    direct bilurubin    AST     ALP    sr. Proteins 
Chest x ray    abdomen x ray erect AP view 
Ultrasound abdomen 
 
 
CT score 
A – NORMAL PANCREAS 
B – ENLARGEMENT OF PANCREAS – 2 points 
C – INFLAMATORY CHANGES IN PANCREAS AND 
PERIPANCREATIC FAT – 2 points 
D – ILLDEFINED SINGLE FLUID COLLECTION – 4 points 
E – 2 OR MORE POORLY DEFINED FLUID COLLECTION – 4 points 
 
PANCREATIC NECROSIS 
NONE  - 0 
LESS THAN 30% - 2 
30 to 50% - 4 
MORE THAN 50% - 6 
EXTRA PANCREATIC COMPLICATIONS – 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a: acute physiology score (12 
variables) 
high abnormal rage  low abnormal range 
Physiological Variables +4 +3 +2 +1 0 +
1 
+2 +
3 
+4 
Temperature – rectal (°C) >41 39-40.9  38.5–
38.9 
36–38.4 34–
35.9 
32–33.9 30–
31.9 
<29.0 
Mean arterial pressure (mm hg) >160 130–159 110–129  70–109  50–69  <49 
heart rate-ventricular response >180 140–179 110–139  70–109  55–69 40–
54 
<39 
Respiratory rate non ventilated 
or ventilated 
>50 35–49  25–34 12–24 10–
11 
6–9  <5 
Oxygen: A – a DO or 
PaO (mm hg) FiO2 > 0.5 
record A – aDO2 
FiO < 0.5 record only PaO 
2                                                              
2 
>500 350-499 200–349  <200 
PO 
>70 
2 
PO 
61–70 
 PO 
55–60 
PO <55 
Arterial ph >7.7 7.6–7.69  7.5-7.59 7.33–
7.49 
 7.25–
7.32 
7.15–
7.24 
<7.15 
Serum hCO  – only if no 
ABGs 
3 
>52 41.5–1.9  32–40.9 23–31.9  18–21.9 15–
17.9 
<15 
Serum sodium (mmol/I) 180 160–179 155–159 50–154 130–
149 
 120–
129 
111–
119 
<110 
Serum potassium (mmol/I) >7 6–6.9  5.5–5.9 3.5–5.4 3–3.4 2.5–2.9  <2.5 
Serum creatinine (umol/l) >350 200–340 150–190  60–140  <60   
haematocrit (%) >60  50–50.9 46–49.9 30–45.9  20–29.9  <20 
White Blood cell court (x1000 
/mm3) 
>40  20–39.9 15–19.9 30–14.9  1–2.9  <1 
Glasgow Coma Score (GCS) Score = 15 minus actual GCS 
APACHE II SCORE 
 
 
 
 
 
 
B. age points 
age years Points History Points for 
elective 
surgery 
Points for 
emergency 
surgery 
and non- 
operative 
patients 
 
 
apache ii score: 
sum of a + B + C 
> 44 0 Liver: Biopsy proven cirrhosis and 
documented portal hypertension or prior 
episodes of hepatic failure 
2 5 A: APS score 
45–54 2 Cardiovascular NYhA class IV 2 5 B: Age Points score 
55–64 3 Respiratory eg. Severe COPD, hypercapnia, 
home O2 pulmonary hypertension 
2 5 C: Chronic health 
points score 
65–74 5 Renal chronic dialysis 2 5  
> 75 6 Immunocompromised 2 5 Total apache II 
 
 
DEFINITIONS FOR ACUTE PANCREATITIS ACCORDING TO 
ATLANTA CLASSIFICATION
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Criteria of illness severity in acute pancreatitis 
Local complications  Necrosis: focal or diffuse area of non 
viable pancreatic parenchyma, with 
necrosis of peripancreatic fat (> 30% of 
the gland or > 3 cm) 
Pseudocyst: pancreatic juice collection 
surrounded by a wall of granulation or 
fibrous tissue that is developed as a 
consequence of acute or chronic 
pancreatitis or pancreatic traumatism 
Abscess: pus collection well defined 
that has scarce or no amount of 
pancreatic necrosis 
Systemic 
complications 
(organic failure)  
Respiratory failure: PaO2 < 60 mmHg 
Shock: systolic BP < 90 mmHg 
Renal failure: creatinine > 2 mg/dL 
after rehydration 
Upper gastrointestinal bleeding: > 500 
mL/24hrs 
Bad prognosis data Ranson’s scale ≥ 3 
APACHE II scale ≥ 8 
 
 
 
MANAGEMENT 
Patients were broadly divided into two groups. Those who had pancreatic 
CT score <6 and APACHE II score was less than 8 were termed as mild 
pancreatitis. Patients with CT score> 6 and APACHE II score more than 8 were 
termed as severe pancreatitis and were admitted in intensive care unit. All 
patients of mild pancreatitis were managed conservatively. Fluid resuscitation at 
the rate of 150 – 200ml/hour using normal saline,dextrose normal saline and 
ringer lactate solution. Strict hourly urine input and output chart was 
maintained. Urine output was maintained to more than 0.5ml/kg/hour. Diuretics 
was used in patients with low output after measuring renal parameters, blood 
pressure and central venous pressure on ventilator patients. Antibiotics given 
include ceftriaxone 1g i.v b.d, amikacin 250mg i.v b.d, metronidazole 500mg i.v 
, piperecillin tazobactam 4.5g i.v b.d. Octeotride 100mg tds was used in severe 
pancreatitis patients. Serial blood investigations were done. Patients with 
hyperglycemia were started on regular insulin.  
Those having random blood glucose of more than 250mg% were started 
on 5 units of actrapid insulin in 0.9% DNS solution.  Diuretics were used in 
patients with elevated renal parameters. Hypokalemia less than 3.5 meq/l was 
corrected with intravenous infusion of potassium. 2 ampules each containing 
20meq/l were given as a continuous infusion over 4 – 6 hours in normal saline 
through a peripheral line. Hypocalcemia of less than 8meq/l was corrected with 
10% of 10ml calcium gluconate in 100ml normal saline over 10 – 20 minutes. 
 
 
Patients with severe acute respiratory distress syndrome as evidenced by 
bilateral pulmonary crepitations, fluffy lung infiltrates (groung glass 
appearance) and hypoxia less than 90% were ventilated and were treated with 
antibiotics, hydrocortisone 100mg i.v tds, soda bicarbonate and chest 
physiotherapy.  All patients were kept nil per oral for first few days due to 
abdominal pain, anorexia and vomiting. Those with mild pancreatitis were 
started on sips of water as soon as patient tolerated. Soft diet containing less fat 
was started the following day. 
Mild pancreatic ascites, pancreatic pleural effusion and acute fluid 
collection in the lesser sac were managed conservatively and eventually 
subsided. 
 One patient developed massive ascites and did not resolve by the end of 
3
rd
 week. Pigtail catheter insertion was done and daily ascetic tapping was done 
not more than 1 litre. Patient eventually developed external pancreatic fistula as 
evidenced by high amylase content in ascetic fluid. The patient also had more 
than 5o% necrosis on contrast CT.  Since the patient was symptomatic at the 
end of 4 weeks, an elective delayed pancreatic necrosectomy was done.  
                      
 Another patient had infected pancreatic necrosis as evidenced by gas in 
CT abdomen and pancreatic necrosectomy was done. In both patients, abdomen 
was opened in midline. Ascitic fluid sucked out. The hepatic flexure and splenic 
flexure were mobilized and taken down. Duodenum was mobilized till inferior 
venecava. Gastrocolic omentum was opened and lesser sac entered. With gentle 
 
 
finger dissection, all the necrosum was debrided from the body and tail of 
pancreas. Minimal oozing was controlled by packing and suturing the 
pancreatic tissue/ducts with silk. Two large bore abdominal drains were kept 
and abdomen closed in single layer. Post operatively patients were kept nil per 
oral and treated with intravenous fluids, antibiotics, octeotride, analgesics and 
proton pump inhibitors. Patients developed glucose intolerance and insulin was 
started. Oral fluids was started on 10
th
 post op day. Drainage tube removed on 
12
th
 post op day. 
 
         After collection of the necessary data, the mean age of presentation of 
pancreatitis, gender distribution was found. Ultrasound abdomen, chest x – ray 
findings, APACHE II score and CT score were tabulated. Complications during 
the treatment period were also assessed. A correlation between APACHE II 
score , CT score and the severity of acute pancreatitis was determined. 
 
 
OBSERVATION 
 
 A total of 50 patients admitted during the period from September 2011 to 
November 2013 at K.A.P.V. Government Medical college Hospital were 
included in the study. After admission the data regarding the patient were 
entered into the proforma and followed up until discharge/death. The data of  50  
patients were entered in the master chart and analysed. The data obtained were 
compared and the observations done were given below. 
Age distribution: 
 
 
No. of patients Percent 
< 30 4 8 
30 – 40 10 20 
40 – 50 12 24 
50 – 60 14 28 
60 – 70 7 14 
70 – 80 2 4 
> 80 1 2 
Total 50 100 
 
 
 
 
 
 
 
 
 
SEX DISTRIBUTION  
  
Gender No. of patients Percent 
Female 11 22 
Male 39 78 
Total 50 100 
 
 
 
 
 
 
 
 
 
 
SIGNS AND SYMPTOMS: 
  Yes (%) No (%) 
Abdomain pain 50(100) 
 Vomiting 50(100) 
 Alcohol 37(74) 13(26) 
Epi Gaurding 50(100) 
 Sr. Amylase 50(100) 
 LFT 11(22) 39(78) 
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                  
 
 
 
CXR 
   No. of patients(%) 
Normal 45(90) 
Abnormal (pleural effusion, fluffy 
infiltrates) 5(10) 
 
 
USG 
   No. of patients(%) 
Diffusely enlarged pancreas 34 (68) 
Diffusely enlarged pancreas,gallstone + 5 (10) 
Enlarged pancreas 1 (2) 
Pancreas not visualised 10 (20) 
Total 50 (100) 
 
 
 
 
 
 
 
 
 
Statistics 
   
  Age 
Apache II 
Score CT Score 
No. of patients 50 50 48 
Missing values 0 0 2 
Mean 48.38 6.58 5.21 
Median 48.5 5.5 6 
Mode 55 0 6 
Std. Deviation 13.23 4.73 1.97 
Variance 174.93 22.41 3.87 
Skewness 0.17 0.29 -0.79 
Std. Error of Skewness 0.34 0.34 0.34 
Kurtosis -0.42 -0.97 1.22 
Std. Error of Kurtosis 0.66 0.66 0.67 
a. Multiple modes exist. The smallest value is 
shown 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPLICATIONS: 
C1. ACUTE FLUID COLLECTION 
C2. VENOUS THROMBOSIS 
C3. ACUTE RESPIRATORY DISTRESS SYNDROME 
C4. PANCREATIC ASCITES/ EFFUSION 
C5. PARALYTIC ILEUS 
C6. ORGAN FAILURE/ MULTIORGAN DYSFUNCTION 
SYNDROME 
C7. PANCREATIC NECROSIS 
C8. INTESTINAL OBSTRUCTION 
C9.   HYPOCALCEMIA/HYPERGLYCEMIA 
C10.  PSUEDOCYST 
C11.  INTESTINAL PERFORATION 
C12.  DIC/ ENCEPAHLOPATHY 
 
 
 
 
 
 
 
 
 
Complications 
  
 
    Presence (%) Absence (%) 
C1 12(24%) 38(76%) 
C2 
 
50(100%) 
C3 5(10%) 45(90%) 
C4 5(10%) 45(90%) 
C5 35(70%) 15(30%) 
C6 5(10%) 45(90%) 
C7 46(92%) 4(8%) 
C8 
 
50(100%) 
C9 10(20%) 40(80%) 
 
Statistical tests used : Chi-Square test and Fisher's exact test 
   
          Null hypothesis : There is no association between APACHE II Score and 
Complication 
   
          Alternative hypothesis: There is a association between APACHE II Score and 
Complication 
  
 
 
 
Complications 
 
Apache II 
Score Total 
P 
Value 
Result    
  
< 8 > 8 
   
c1 
Absence 30 8 38 
<0.001 
Highly 
Significant 
   
Presence 0 12 12 
   
c3 
Absence 30 15 45 
0.007 Significant    
Presence 0 5 5 
   
c4 
Absence 30 15 45 
0.007 Significant    
Presence 0 5 5 
   
c5 
Absence 3 12 15 < 
0.001 
Highly 
Significant 
   
Presence 27 8 35 
   
c6 
Absence 30 15 45 
0.007 Significant    
Presence 0 5 5 
   
c7 
Absence 3 1 4 
0.641 Not Significant    
Presence 27 19 46 
   
c9 
Absence 30 10 40 
<0.001 
Highly 
Significant 
   
Presence 0 10 10 
   
Total 
 
30 20 50 
     
Inference: 
         
          The above table shows that there is a association between APACHE II Score >8 and 
Complication c1,c3,c4,c5,c6 and c9 and there is no association between APACHE II 
Score and complication c7. 
 
 
 
 
 
 
 
Statistical tests used : Chi-Square test and Fisher's exact test 
   
Null hypothesis : There is no association between CT Score and 
Complication    
Alternative hypothesis: There is a association between CT Score and 
Complication    
Complications 
CT 
Score 
Total P Value Result 
   
  
< 
6 
> 
6    
c1 
Absence 33 5 38 
0.046 Significant    
Presence 7 5 12 
   
c3 
Absence 39 6 45 
0.004 Highly Significant    
Presence 1 4 5 
   
c4 
Absence 37 8 45 
0.258 Not Significant    
Presence 3 2 5 
   
c5 
Absence 13 2 15 
0.44 
Not Significant 
 
 
 
   
Presence 27 8 35 
   
c6 
Absence 40 5 45 
<0.001 Highly Significant    
Presence 0 5 5 
   
c7 
Absence 4 0 4 
0.571 Not Significant    
Presence 36 10 46 
   
c9 
Absence 37 3 40 
<0.001 Highly Significant    
Presence 3 7 10 
   
Total 
 
40 10 50 
     
 
Inference:          
      The above table shows that there is a association between CT Score >6 and 
Complication c1,c3,c6 and c9 and there is no association between CT Score and 
complication c4,c5 and c7. 
 
 
 
 
    DISCUSSION 
 
A total of 50 patients admitted during the period from September 2011 to 
November 2013 at K.A.P.V. Government Medical college Hospital were 
included in the study. After admission the data regarding the patient were 
entered into the proforma and followed up until discharge/death. The data of 50  
patients were entered in the master chart and analysed. 
Average age of presentation of acute pancreatitis in our study was  48 
years. 
Acute pancreatitis due to alcohol abuse was more common  in age group 
between 50 - 60 years. 
There is male pre ponderance in patients with acute pancreatitis 
The Male to Female ratio is almost 4: 1 
All the patients with acute pancreatitis had upper abdominal pain and vomiting. 
Alcohol abuse was the common cause of acute pancreatitis which accounts 
for 90% of the cases followed by gall stone disease which accounts for 10% 
of the cases. 
Serum amylase was the first line of investigation in all cases. All cases 
showed hyperamylasia with serum amylase levels of more than 1000 IU. Liver 
function test was normal in 45 patients. Only 5 patients with gall stone disease 
showed elevated total bilirubin, direct bilirubin and alkaline phosphatase levels. 
Complete blood count showed elevated white blood cells in all patients. 5 
 
 
patients showed elevated haematocrit of more than 44%. 10 patients had blood 
sugar of more than 250mg%.     10 patients had elevated renal parameters . 10 
patients had hyponatremia (sodium less than 135meq/l)  and hypokalemia 
(potassium less than 3.5meq/l)  due to severe vomiting. Arterial blood gas 
analysis was done and it showed that 10 patients had metabolic acidosis as 
evidenced by decreased pH and decreased bicarbonate. 8 patients had  
hypocalcemia with calcium levels of less than 8 meq/l. 5 patients had signs of 
Acute respiratory distress syndrome as evidenced by fluffy lung infiltrates on 
chest x ray, saturation of less than 80% and partial pressure of oxygen of less 
than 60 mm Hg. Glasgow coma scale was 15/15 in all patients.  
Chest infiltrates were present in 5 patients. Pleural effusion  was present in 5 
patients 
Ultra sound abdomen 
Diffusely enlarged and hypoechoic gland was present in 30 patients. Gall 
stone was present in 5 patients. There were no stones in the common bile duct at 
the time of presentation. Extra pancreatic fluid collections (lesser sac, anterior 
Para renal space) were present in 5 patients. 10 patients had dilated bowel loops 
and hence could not be assessed properly with ultrasound abdomen. Routine 
blood investigations and arterial blood gas analysis was done on the day of 
admission for all patients and APACHE II score was calculated. We found in 
our study that the mean APACHE score was 6.58, the standard deviation is 
4.73.  
 
 
CT SCORE: 30 patients had GRADE C i.e. inflammatory changes in 
pancreas and peripancreatic fat. 5 patients had gall stone disease.5 patients had 
GRADE D i.e., ill-defined single fluid collection. 5 patients had GRADE E i.e. 
2 or more poorly defined fluid collection.  30 patients had necrosis of less than 
30%.10 patients had necrosis of 30 to 50%.  10 patients had necrosis of more 
than 50%. The mean CT score was found to be 5.21 and the standard deviation 
was 1.97. Patients were assessed in the ward for the complications and it was 
found that paralytic ileus, acute fluid collection, hyperglycemia, hypocalcemia, 
hypokalemia were common. 
 
                   Based on all the above information, a corerelation between acute 
pancreatitis, APACHE II score and CT score was established. We found that 
there is a significant correlation between APACHE score  > 8, CT score > 6 and 
complications namely paralytic ileus, metabolic disturbances, acute fluid 
collection, pancreatic ascites, pancreatic effusion and acute respiratory distress 
syndrome.  
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
In our study, the main etiologic factor was found to be alcohol. Acute 
pancreatitis is common in young and middle aged males. Mild pancreatitis as 
evidenced by CT score < 6and APACHE II score < 8 have better prognosis.. 
Oral diet is tolerated faster, sepsis is minimal and local complications are lesser. 
Severe pancreatitis as evidenced by CT scores > 6 and APACHE II score of > 8 
have severe metabolic and electrolyte disturbances. Prognosis is guarded 
specially those who have acute respiratory distress syndrome and features of 
multi organ dysfunction syndrome. Acute fluid collection, pancreatic ascites, 
pancreatic effusion eventually subsided on their own. External pancreatic 
fistula, organized pancreatic necrosis and infected pancreatic necrosis were 
taken up for surgery (pancreatic necrosectomy and debridement of body and tail 
respectively). 
There is a significant correlation between APACHE score  > 8, CT score 
> 6 and complications namely paralytic ileus, metabolic disturbances, acute 
fluid collection, pancreatic ascites, pancreatic effusion and acute respiratory 
distress syndrome.  
 
 
 
 
 
REVIEW OF RECENT LITERATURE 
 
The following studies are comparable to our study. 
1. Acute Pancreatitis: Assessment of Severity with Clinical and CT 
Evaluation; Emil J. Balthazar, MD. 
2. The clinical prognostic indicators of Acute pancreatitis by  APACHE II 
scoring; Dr. Rithin suvarna; AJ Institute of Medical Sciences; Mangalore; 
India. (13) 
3. World journal of Acute Pancreatitis update; Dulce M Santamaria ; Carlos 
Taxonera; Maneul Giner.(14) 
4. Elmer press; Gastroenterology research; predicting acute pancreatitis 
severity: comparision of prognostic scores; Marco Simoes ; Patricia 
Alves 
 
 In all the above studies, the correlation between Acute Pancreatitis, CT 
grading and APACHE scoring were studied. It was found that patients with CT 
score of more than 6 or more than 30% necrosis and APACHE score of more 
than 8 had more complications and had poor prognosis. Patients with APACHE 
II score of less than 8 had fewer complications and good prognosis. 
 
 
  
 
 
RECENT ADVANCES IN PANCREATITIS
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Enteral Nutrition in Acute Pancreatitis (11): 
 Usually patients with acute pancreatitis are kept nil per oral. The 
rationale behind this is to give rest to pancreas. Also the patients are anorectic 
and have severe vomiting. This concept of putting pancreas to rest was 
developed by Ragins. However it was in canines. Pancreas secretes protein 
enzymes, fluid volume and bicarbonates. Of this protein enzymes are 
responsible for auto digestion of gland. Hence suppression of only protein 
enzymes will be sufficient to halt the disease process. Pancreatic secretion is 
stimulated by three levels. Cephalic phase mediated through vagus, gastric 
phase mediated through gastrin and intestinal phase mediated through vagus, 
CCK, VIP and secretin like hormone. Pancreatic secretion reaches maximum 
when food is taken in mixed form of 20kcal/lg containing more of fat. 
Pancreatic secretion is significantly reduced when food has bypassed stomach 
and duodenum and is directly given around 60cms from ligament of treitz 
(bypassing all three phases of pancreatic stimulation). Also, elemental feeds 
cause less stimulation as they contain less fat. The free fatty acids combine with 
trypsin and levels of trypsin is reduced. All patients must receive enteral 
nutrition as it preserves intestinal mucosal integrity and chances of infection are 
less. 
Although the use of glutamine supplementation, immunonutrition and 
prebiotics, and/or probiotics is conceptually sound and attractive, their use is not 
 
 
supported by large-scale studies .The precise timing for enteral nutrition is not 
addressed but early enteral nutrtion within 36 hours is beneficial. The chances 
of pancreatic infection, multi organ failure are less. Enteral nutrition is best 
provided by placement of nasojejunal tubes either endoscopically or 
ragraphically. Prolonged feeding for 4 – 6 weeks may need laproscopic 
placement of jejunal tubes. Feeds can be given in bolus or continuous infusion. 
Generally, for mild AP it is recommend to initiate EN if patients cannot 
consume normal food after 5–7 days. For severe AP nutritional support is 
indicated when it becomes evident that the patient will not be able to tolerate 
oral intake for a prolonged period of time, for example, for at least 7 days. This 
assessment can usually be made within the first 3-4 days of admission. EN 
should be supplemented by parenteral nutrition if needed. Also, in severe 
pancreatitis with complications such as pancreatic fistulas, ascites, and 
pseudocysts, tube feeding can be given uneventfully. If gastric feeding is not 
tolerated, the jejunal route should be tried and continuous feeding in stead of 
bolus feeding should be used. In gastric outlet obstruction, feeding beyond the 
obstruction with the tube tip distal to the obstruction should be tried. If this is 
impossible, parenteral nutrition should be given. In case of surgery for 
complications of AP, an intraoperative jejunostomy for postoperative feeding is 
feasible. 
 
 
 
 
SCORING SYSTEM
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A recent development in scoring system in acute pancreatitis during the 
first 24 hours is Bedside Index of Severity in Acute Pancreatitis (BISAP). 
1 point for each criteria: 
1. Blood urea nitrogen level more than 8.9mmol/l 
2. Impaired mental status 
3. Systemic inflammatory response syndrome 
4. Age > 60 years 
5. Pleural effusion on radiography. 
A score of more than 3 indicates increased risk of death. 
Criteria for systemic inflammatory syndrome: 
1. heart rate > 90/min 
2. respiratory rate more than 20/ min or partial pressure of carbondioxide 
<32mm Hg. 
3. Body temperature <36 or >38leucocyte count < 4000 or >12000/ cumm 
or >10% immature neutrophils (bands).  
 
 
 
 
 
 
 
 
PROFORMA 
 
Name:     Age:     Sex: 
I.P No.:     Ward: 
Date of admission:   
Date of discharge: 
I PRESENTING FEATURES 
1. Abdominal pain 
2. Vomiting 
3.  Fever 
4. Any other 
II. PAST HISTORY 
H/O JAUNDICE 
H/O GALL STONES 
H/O SURGERIES/ ERCP 
III. MENSTRUAL AND OBSTETRIC HISTORY 
IV. FAMILY HISTORY 
V.PERSONAL HISTORY 
V. GENERAL EXAMINATION 
BUILT & NOURISHMENT 
PULSE RATE  
BLOOD PRESSURE                   MEAN ARTERIAL PRESSURE 
 
 
RESPIRATORY RATE 
TEMPERATURE 
GCS 
SIGNS OF DEHYDRATION 
ANAEMIA 
JAUNDICE 
CYANOSIS 
CLUBBING 
LYMPHADENOPATHY 
PEDAL OEDEMA 
VI. EXAMINATION OF ABDOMEN 
1. EPIGASTRIC TENDERNESS 
2. GAURDING 
3.  RIGIDITY 
4.  GREY TURNER SIGN, CULLEN’S SIGN, FOX SIGN 
5.  ASCITES 
6. PER RECTAL EXAMINATION –  
7.  PER VAGINAL EXAMINATION –  
VII. EXAMINATION OF OTHER SYSTEMS 
RESPIRATORY SYSTEM – PLEURAL EFFUSION/ CONSOLIDATION 
CARDIOVASCULAR SYSTEM 
CENTRAL NERVOUS SYSTEM – GCS -  
 
 
VIII. INVESTIGATIONS 
Hb% 
Total count 
Differential count 
ESR 
Blood Urea 
Blood sugar 
Serum creatinine 
Serum electrolytes 
Serum amylase 
Total bilurubin 
Direct bilurubin      Indirect bilurubin 
AST                        ALT                   ALP  
Serum proteins 
X-Ray abdomen erect 
Chest X-Ray PA view 
Ultrasonogram abdomen 
PLAIN/ CONTRAST CT FINDING  -  BALTHAZAR SCORING –  
A – NORMAL PANCREAS 
B – ENLARGEMENT OF PANCREAS 
C – INFLAMATORY CHANGES IN PANCREAS AND 
PERIPANCREATIC FAT 
 
 
D – ILLDEFINED SINGLE FLUID COLLECTION 
E – 2 OR MORE POORLY DEFINED FLUID COLLECTION 
PANCREATIC NECROSIS 
NONE  - 0 
LESS THAN 30% - 2 
30 to 50% - 4 
MORE THAN 50% - 6 
EXTRA PANCREATIC COMPLICATIONS – 2 
 
BALTHAZAR SCORING/ MODIFIED CT SEVERITY INDEX-  
 
APACHE II SCORING 
          PARAMETER            SCORE 
     Temperature  
Mean arterial pressure  
Heart rate  
Respiratory rate  
A-aPo2  
PAo2  
Ph  
Bicarbonate  
Sodium  
 
 
Potassium  
Creatinine  
PCV  
WBC  
GCS  
Age adjustment  
Chronic health adjustment  
Total   
 
    BASED ON APACHEII SCORING AND CT GRADING: 
1. MILD PANCREATITIS 
2. SEVERE PANCREATITIS 
MANAGEMENT 
1. FLUID RESUCITATION 
2. ELECTROLYTE CORRECTION 
3. STOMACH DECOMPRESSION 
4. ANTIBIOTICS 
5. ANALGESICS 
6. OCTEOTRIDE 
7. CALCIUM GLUCONATE 
8. HOURLY INPUT OUTPUT 
9. TOTAL INPUT OUTPUT 
 
 
COMPLICATIONS  
LOCAL REGIONAL SYSTEMIC 
ACUTE 
FLUID 
COLLECTION 
VENOUS 
THROMBOSIS 
ACUTE RESPIRATORY DISTRESS 
SYNDROME 
PANCREATIC 
ASCITES/ 
EFFUSION 
PARALYTIC 
ILEUS 
ORGAN FAILURE/ MULTIORGAN 
DYSFUNCTION SYNDROME 
PANCREATIC 
NECROSIS 
INTESTINAL 
OBSTRUCTION 
HYPOCALCEMIA/HYPERGLYCEMIA 
PSUEDOCYST INTESTINAL 
PERFORATION 
DIC/ ENCEPAHLOPATHY 
 
OUTCOME OF THE PATIENT DURING HOSPITAL STAY: 
 
 
CONSENT 
xg;Gjy; gbtk; 
 
jiyg;G: 
 
Acute Pancreatitis (fizag; Gz;)d; tPhpaj;ij> kUj;Jtg; 
ghpNrhjidfs; %yk; Muha;J mwpjy;. 
 
gq;FngWgth; ngah;  :  
ghpNrhjid nra;Ak; ,lk; : 
ghpNrhjid vz;   : 
Nehahspapd; vz;   : 
 
 1.ehd; ,g;ghpNrhjidapd; jfty; gbtk; 
………………..Njjpapl;l gbtjij gbj;J Ghpe;Jf; nfhz;Nld; vd 
cWjpaspf;fpNwd;. mjpy; cs;s re;Njfq;fis epth;j;jp nra;aTk; 
tha;g;G mspf;fg;gl;Nld;. 
 
 2.vd;Dila gq;fspg;G Ra tpUg;gj;jpd; Nghpy; jhd; 
vd;gijAk;> ,jpy; ,Ue;J ve;j epiyapYk; fhuzk; njhptpf;fhky; 
tpsfpf;nfhs;sTk; vdf;F chpikAs;sijAk; mwpe;Jf; nfhz;Nld;. 
,J vd;Dila rp kUj;Jt rpfpr;iria ve;j tpjjjpYk; ghjpg;G 
Vw;gLj;jhJ vd cah;e;Jf; nfhz;Nld;. 
 
3.vd;Dila ghpNrhjid KbTfis vg;nghOJ 
Ntz;LkhdhYk; gad;gLj;jpf;nfhs;s ,r;Nrhjid mjpfhhpfSf;F 
KO chpik mspf;fpNwd;. 
 
4.,jd; %yk; ehd; ,r;Nrhjidapy; gq;Fngw KO rk;kjk; 
mspf;fpNwd;. 
1)Nehahspapd; ifnag;gk; 
 
 
2)Nehahspapd; cwtpdh; ifnahg;gk; 
3)ghpNrhjfhpd; ifnahg;gk; 
jhq;fSf;F (ACUTE PANCREATITIS) fizaj;jpy; 
Gz;zhfpAs;sjhy; ehq;fs;op cq;fsplk; rpy Nfs;tpfs;> 
,uj;jg;ghpNrhjid> USG Scan kw;Wk; CT-Scan Mfpait nra;J 
jq;fs; Nehapd; jPtpuj;ij mwptjw;fhd Nrhjidapy; jq;fis 
,idj;Jf; nfhs;tjw;fhd xg;Gjy; gbtk; ,e;j Nrhjidapy; 50 
Nehahspfs; gq;Nfw;ghh;fs;. ,e;j Nrhjidapy; ,izj;Jf; 
nfhs;tjw;Fk;> ve;j epiyapy; Ntz;Lnkd;whYk; ntspNaWtjw;Fk; 
jq;fSf;F KO Rje;jpuk; mspf;fg;gLk;. ,r;Nrhjidapy; 
,izj;Jf; nfhs;tjdhYk;> ,y;iynad;whYk; rpfpr;irapy; 
jq;fSf;F ve;jtpj khWjy;fSk; ,y;iy vd cWjpaspf;fpNwhk;. 
NkYk; ,jpy; jq;fis ,izj;Jf;nfhs;tjpd; %yk; jhq;fs; 
gpd;tUk; re;jjpapdUf;F Nkw;nrhd;d Nehapd; mwpFwpfisf; 
nfhz;L NkYk; rpwe;j Kiwapy; rpfpr;iraspf;Fk; tha;g;ig 
Vw;gLj;jpf; nfhLf;fpwPh;fs;. ,jpy; ,iztjdhy; jhq;fs; ,uz;L 
thuq;fs; tiu kUj;Jtkidapy; jq;f Nehplyhk;. ,jdhy; 
jq;fSf;F Vw;gLk; rpukq;fshd ,uj;jf;fl;b (Hematoma at arterial 
Puncture)> xt;thik (Anaphylaxis for contrast) Mfpait Vw;gl tha;g;G 
cs;sJ vd;gijAk; mjw;fhd rpfpr;irfs; ,k;kUj;Jtkidapy; 
cs;sJ vd;gijAk; jq;fSf;F njhptpj;Jf; nfhs;fpNwhk;. ,jd; 
%yk; ngwg;gLk; midj;J jfty;fSk; kpfTk; ghJfhg;ghf 
itf;fg;gLk; vd cWjpaspf;fpNwhk;. ,r;Nrhjid vq;fs; 
Mrphpah;fs; kw;Wk; Nguhrphpah;fshy; fz;fhdpf;fg;gLk;. ,jpy; 
gq;Nfw;gjw;F vq;fSila kdg;G+h;tkhd ed;wpia jq;fSf;F 
njhptpj;Jf;nfhs;fpNwhk;. 
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1 Kuppusamy 58/m y Y y y y n Fluffy lung 
infiltrates 
Diffusely enlarged pancreas 17 8 1,3,4,5,6,7,9 
2 Kumarasamy 48/M y Y y y y y N Pancreas not visualised 12 6 1,4,7 
3 Pitchai 61/m y Y y y y n N Diffusely enlarged pancreas 11 6 7,9 
4 Senthilkumar 70/m y Y y y y n N Diffusely enlarged pancreas 11 6 7,9 
5 Kumar 49/m y Y y y Y y N Pancreas not visualised 10 6 3,5,,7, 
6 Thiyagarajan 46/m y Y y y Y n N Pancreas not visualised 12 6 1,4,7 
7 Kolandaivel 68/m y Y y y Y n N Diffusely enlarged pancreas 10 6 1,4,7 
8 Vetrivel 47/m y Y y y Y n N Pancreas not visualised 10 6 1, 7 
9 Hemalatha 56/f y Y n y Y y N Diffusely enlarged 
pancreas,gallstone + 
13 8 1, 7, 9 
10 Tamilselvi 44/f y Y n y Y n N pancreas not visualised 10 6 7,9 
11 Velmurugan 45/m y Y y y Y y N Pancreas not visualised 10 6 1, 7 
12 Kalaiarasi 50/f y Y n y Y n N Pancreas not visualised 6 6 NIL 
13 Prabhu 75/m y Y y y Y n N Diffusely enlarged pancreas 8 6 NIL 
14 Palanisamy 60/m y Y y y Y n N Diffusely enlarged pancreas 6 2 5,7 
15 Perumal 80/m y Y y y Y n N Diffusely enlarged pancreas 9 6 1, 7 
16 Sudha 24/f y Y n y Y y N Diffusely enlarged pancreas 1 6 5,7 
17 Ravikumar 36/m y y y y Y n N Diffusely enlarged pancreas 5 4 5,7 
 
 
18 Thangaraj 37/m y y y y Y n N Diffusely enlarged pancreas 4 4 5,7 
19 Periyammal 39/f y y N y Y n N Diffusely enlarged pancreas 4 4 5,7 
20 Kandhasamy 38/m y y y y Y n N Diffusely enlarged pancreas 4 4 5,7 
21 Sivakumar 40/m y y y y Y n N Diffusely enlarged pancreas 4 4 5,7 
22 Nagur pitchai 28/m y y n y Y y N Diffusely enlarged 
pancreas,gallstones+ 
3 6 5,7 
23 Premalatha 43/f y y n y Y n N pancreas not visualised 3 4 5,7 
24 Shanthi 26/f y y n y Y y N Diffusely enlarged 
pancreas,gallstones+ 
0 6 5,7 
25 Jayaraj 35/m y Y y y Y n N Diffusely enlarged pancreas 0 4 5,7 
26 Kaderesan 33/m y Y y y Y n N Diffusely enlarged pancreas 0 4 5,7 
27 Aiyappan 31/m y Y y y Y n N Diffusely enlarged pancreas 3 4 5,7 
28 Vivek 34/m y Y y y Y n N Diffusely enlarged pancreas 0 4 5,7 
29 Pushpavalli 41/f y Y n y Y n N Pancreas not visualised 4 4 5,7 
30 Vinoth 32/m y Y y y Y N N Diffusely enlarged pancreas 0 4 5,7 
31 Kannaghi 57/f y Y n y Y Y N Diffusely enlarged 
pancreas,gallstones+ 
7 8 5,7 
32 Ganeshan 58/m y Y y y Y N N Diffusely enlarged pancreas 3 0 5,7 
33 Parimala 42/f y Y n y Y N N Pancreas not visualised 1 4 5,7 
34 Ramesh 55/m y Y y y Y N N Diffusely enlarged pancreas 2 4 5,7 
35 Meena 54/f y Y n y Y N N Diffusely enlarged pancreas 10 2 1 , 7, 9 
36 Suresh 51/m y Y y y Y N N Diffusely enlarged pancreas 5 6 5,7 
37 Subramani 52/m y Y N y Y N N Diffusely enlarged 
pancreas,gallstone+ 
2 8 5,7 
38 Chandran 60/m y y y y Y N N Diffusely enlarged pancreas 5 4 5,7 
39 Vasu 53/m y y y y Y N N Diffusely enlarged pancreas 4 6 5,7 
 
 
40 Arumugam 65/m y y y y Y N N Diffusely enlarged pancreas 8 6 5,7 
41 Murugan 68/m y y y y Y N N Diffusely enlarged pancreas 9 6 5,7 
42 Devanathan 59/m y y y y Y N N Diffusely enlarged pancreas 2 0 5,7 
43 Mohan 55/m y y y y Y N N Diffusely enlarged pancreas 11 0 5,7 
44 Boopathy 51/m y y y y Y N N Diffusely enlarged pancreas 3 4 5,7 
45 Manickam 25/m y y y y Y N N Diffusely enlarged pancreas 0 4 NIL 
46 Kathirvel 60/m y y y y Y N Fluffy lung 
infiltrates,left 
pleural effusion 
Diffusely enlarged pancreas 16 8 1,3,4,5,6,7,9, 
47 Karthikeyan 40/m y y y y Y n Fluffy lung 
infiltrates, left 
pleural effusion 
Diffusely enlarged pancreas 12 8 3,5,6,7,9 
48 Narayanan 55/m y y y y Y y Fluffy lung 
infiltrates, right 
pleural effusion 
Diffusely enlarged pancreas 15 8 5,6,7,9 
49 Sangapillai 47/m y y y y Y y Fluffy lung 
infiltrates, left 
pleural effusion 
Diffusely enlarged pancreas 12 8 1,3,5,6,7,9 
50 Balamurugan 38/m y y y y y y normal Enlarged pancreas 12 4 1 
 
 
 
LIST OF COMPLICATIONS AND THEIR KEY WORDS USED 
IN MASTER CHART 
 
1. ACUTE FLUID COLLECTION 
2. VENOUS THROMBOSIS 
3. ACUTE RESPIRATORY DISTRESS SYNDROME 
4. PANCREATIC ASCITES/ EFFUSION 
5. PARALYTIC ILEUS 
6. ORGAN FAILURE/ MULTIORGAN DYSFUNCTION 
SYNDROME 
7. PANCREATIC NECROSIS 
8. INTESTINAL OBSTRUCTION 
9. HYPOCALCEMIA/HYPERGLYCEMIA 
10. PSUEDOCYST 
11. INTESTINAL PERFORATION 
12. DIC/ ENCEPAHLOPATHY 
 
 
